Wegovy 0.5 mg: What People Commonly Experience at This Dose

Wegovy is a once-weekly injectable medicine containing semaglutide, a GLP-1 receptor agonist. According to information published on the electronic Medicines Compendium (eMC), the titration schedule is designed to start low and increase gradually — a structure intended to help the body adjust to each new dose level before moving to the next.

Appetite and food noise changes

At 0.5 mg, many people describe a more pronounced reduction in appetite compared with the starting dose. The sensation often described as "food noise" — persistent thoughts about food — is commonly reported to quieten noticeably at this stage. Portion sizes often feel smaller than before, and eating to old habits can feel uncomfortable.

Gastrointestinal side effects

Nausea, constipation, and indigestion are among the most commonly reported experiences at this dose. For many people, these effects are most noticeable in the first few days after an injection and tend to ease as the week progresses. Some people find that eating slowly, choosing smaller meals, and staying hydrated helps them feel more comfortable — though any ongoing or severe symptoms should be discussed with your prescriber or doctor.

Energy and mood

Fatigue and mild headaches are also commonly reported, particularly in the early weeks at a new dose level. These are frequently described as temporary, though individual experiences differ. If you are finding energy or mood changes significant, it is worth noting the pattern carefully so you can raise it with your healthcare professional.

For context on how this dose fits into the broader schedule, see our overview of Wegovy dose strengths and the titration journey, or read about the move to the 1.7 mg stage further along the schedule.

Keeping a clear record of what you notice at each dose stage is one of the most useful things you can do — both for your own understanding and for conversations with your prescriber. GLP Trackr's dose logging feature lets you record the exact dose, date, and time of each injection, so you always have an accurate, timestamped history of where you are in your schedule.

Alongside dose logging, the side-effect tracker lets you note symptoms like nausea, fatigue, or changes in appetite each day, and the app surfaces patterns over time — helping you see whether something is settling down after a dose change or persisting in a way worth flagging. This kind of structured log can be particularly useful to bring to a prescriber appointment rather than relying on memory.

If you are using the 0.5 mg/0.5 ml Wegovy pen, logging each injection in the app also helps you keep track of your pen usage and weekly schedule. You can also explore our guidance on tracking your GLP-1 dose journey for broader tips on staying consistent.

GLP Trackr is free to try for 7 days — download it on the App Store or Google Play and start building a record of your journey from today.

A note on safety: The experiences described here are commonly reported and informational only. If any side effect feels severe, persistent, or worrying, contact your healthcare professional promptly. Decisions about whether to continue, adjust, or change your dose belong entirely with your prescriber — GLP Trackr helps you record your experience so you can have a more informed conversation, but it is not a substitute for their guidance. Any side effects worth reporting can be submitted to your national pharmacovigilance scheme (such as the UK's Yellow Card scheme) and to your prescriber.